The American Society of Hematology has highlighted the need for the training of physicians and scientists, basic and clinical research, in hematology. The training program in hematology at the University of Minnesota addresses this concern by providing: 1) inter- and multi-disciplinary research training in five major realms of hematology;2 senior and junior faculty members of both genders as mentors;3) a fusion of research and clinical training for physician and PhD trainees;4) an outstanding resource-filled environment;and 5) the skills for trainees to both survive and thrive in academic medicine. The overarching objective of the training program is to train physicians and scientists for careers in academic medicine and hematology related research. Our program philosophy is to achieve this by carefully balancing sufficient structure to ensure rigor of the trainee experience and programmatic flexibility to accommodate the different needs of trainees. It is our intention to provide trainees with the basic skills that are adaptable to new paradigms of disease, capable of embracing of new technologies, and committed to the highest ethical standards. This post-doctoral training program will allow six trainees at least two years of research experience. This hematology training program, in the tradition of the last 35 years, is confident that future leader of hematology research will matriculate through the University of Minnesota program.
Advanced research training of doctors and scientists focused on blood diseases is essential to finding cures for leukemia or the prevention of fatal blood clots. This training program will prepare hematologists and scientists to develop new scientifically-based treatments and understandings of these diseases to improve the health and safety of patients will blood diseases.
|Eckfeldt, Craig E; Pomeroy, Emily J; Lee, Robin D W et al. (2016) RALB provides critical survival signals downstream of Ras in acute myeloid leukemia. Oncotarget :|
|Bastian, Thomas W; Duck, Kari A; Michalopoulos, George C et al. (2016) Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain-barrier and impairs iron-dependent hippocampal neuron dendrite development. J Thromb Haemost :|
|Khan, Fatima; Huang, Hans; Datta, Yvonne H (2016) Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation. J Thromb Thrombolysis 42:573-8|
|Matta, B M; Reichenbach, D K; Blazar, B R et al. (2016) Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses. Am J Transplant :|
|Osborn, Mark; Lonetree, Cara-Lin; Webber, Beau R et al. (2016) CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia. Stem Cells Dev :|
|Matta, Benjamin M; Reichenbach, Dawn K; Zhang, Xiaoli et al. (2016) Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. Blood 128:427-39|
|Hermanson, David L; Bendzick, Laura; Pribyl, Lee et al. (2016) Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells 34:93-101|
|Tubo, Noah J; Fife, Brian T; Pagan, Antonio J et al. (2016) Most microbe-specific naÃ¯ve CD4âº T cells produce memory cells during infection. Science 351:511-4|
|Sachs, Zohar; Been, Raha A; DeCoursin, Krista J et al. (2016) Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. Haematologica 101:1190-1199|
|Osborn, Mark J; Webber, Beau R; McElmurry, Ronald T et al. (2016) Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology. J Inherit Metab Dis :|
Showing the most recent 10 out of 89 publications